Update on the availability of Tsoludose (oral solution in single-dose container)

News Healthcare & Pharma Guidance

Date: 11th Jul, 2024 Source: French National Agency for the Safety of Medicines and Health Products (ANSM) Country: France Original Source

Brief

On 15/11/2024, the French National Agency for the Safety of Medicines and Health Products (ANSM) announced that Tsoludose and its imported equivalent Tirosint Solution will no longer be available in France from March 2025. The ANSM advises doctors to stop prescribing Tsoludose or Tirosint Solution and to refer patients to alternative treatments based on levothyroxine, as recommended.

This content is restricted.

Highlights content goes here...

This content is restricted.

French National Agency for the Safety of Medicines and Health Products (ANSM)

RADA.AI

Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?

Suggested

Update on the availability of Tsoludose (oral solution in single-dose container)

Brief

French National Agency for the Safety of Medicines and Health Products (ANSM)

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Verify Email

Tell us more about yourself

Select your work area

Select your country

All set.

Update on the availability of Tsoludose (oral solution in single-dose container)

Brief

French National Agency for the Safety of Medicines and Health Products (ANSM)

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Verify OTP

Enter your Email

Verify Email

Tell us more about yourself

Select your work area

Select your country

All set.